[1] |
QIAN Jin, WANG Fengyan.
Influence factors of serum NT-proBNP level in elderly patients with acute myocardial infarction after PCI and its influence on short-term prognosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 658-665.
|
[2] |
PENG Yong, FAN Jianfeng, XIONG Xuhua, XIAO Dongping, GAO Zhaobo, ZHENG Chunhua.
Effect of iron dextran dispersible tablets on heart failure patients with iron deficiency
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 178-183.
|
[3] |
CHEN Yulin, JIANG Hugang, WANG Xinqiang, LIU Kai, LI Yingdong, AN Tao, ZHAO Xinke.
Effects and mechanism of Ginseng Yixin granules (QSYXG) for heart failure with preserved ejection fraction based on the network pharmacology and molecular docking strategy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1081-1092.
|
[4] |
YANG Sheng, WANG Deguo.
Effects of sakubatril valsartan combined with dagliflozin in the treatment of patients with HFrEF and the effect on serum cTnⅠ and BNP levels
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 1010-1015.
|
[5] |
PENG Juan, FAN Linlin, LI Ranyi, LI Xiaoyu, LV Qianzhou, ZOU Yunzeng.
Progress of pharmacotherapy for heart failure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 373-381.
|
[6] |
LIU Ping, QIU Bo, WU Huizhen.
Pharmacology and clinical evaluation of vericiguat in the treatment of heart failure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(2): 212-218.
|
[7] |
XU Yonghua, SHI Xianghong.
Analysis of the efficacy of torasemide combined with levocarnitine in the treatment of chronic heart failure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(6): 647-652.
|
[8] |
CHEN Lifang, WANG Bo, WANG Weirong.
Research advances of histone deacetylase 3 in cardiovascular diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(1): 88-97.
|
[9] |
ZHAO Wei, WU Youyang, LIN Cong, HUANG Shiwei, CHEN Hao, JIANG Wenbing.
Effects of pterostilbene on myocardial function, myocardial fibrosis and inflammatory response in rats with acute myocardial infarction and on Notch1/eIF3a signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(5): 498-504.
|
[10] |
ZHENG Sanfu, GUO Weixi, LUO Jinzhong, QIN Shuiqing.
Role and mechanism of platelet-derived growth factor/AKT pathway in pressure overload-induced ventricular remodeling
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(2): 167-173.
|
[11] |
FAN Jianfeng,FANG Yi,ZHENG Chunhua.
Clinical efficacy of sacubitril valsartan in the treatment of chronic heart failure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(7): 810-814.
|
[12] |
SHEN Lei, WANG Keke, YANG Jingke, ZHAO Juntao, MENG Xiangguang, YUAN Yiqiang.
Advances in drugs and genetic pharmacology for heart failure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(3): 343-349.
|
[13] |
WEI Zihan,LI Dongbo,YUAN Zheng,LU Ying, YANG Guojie.
Clinical trial of sacubitril/valsartan in the treatment of Pulmonary hypertension (PH) due to left heart disease (LHD)
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(1): 57-62.
|
[14] |
HUANG Ting, WANG Hegui.
Research progress in regulation of heart failure by β-adrenergic-receptor-PKA-AKAP signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(5): 592-596.
|
[15] |
WANG Shibiao, WANG Chengyi, WENG Bin, GUO Xiaofeng, LIN Hai.
Comparison of the efficacy of non-invasive USCOM and milrinone in children with severe pneumonia and heart failure and its effect on brain natriuretic peptide levels
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(12): 1402-1407.
|